The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.10
Bid: 43.10
Ask: 46.90
Change: 1.30 (2.97%)
Spread: 3.80 (8.817%)
Open: 43.10
High: 43.10
Low: 43.10
Prev. Close: 43.70
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

18 Apr 2016 09:40

RNS Number : 4864V
Benchmark Holdings PLC
18 April 2016
 

18 April 2016

 

Benchmark Holdings plc

("Benchmark" or "the Company")

 

Issue of Equity

INVE managers invest €120,000 in Benchmark shares

 

The Company announces that it has allotted 110,873 new ordinary shares of 0.1 pence each ("New Ordinary Shares") to certain managers of INVE Aquaculture Holding B.V. ("INVE"), to be issued on 20 April 2016, for a total consideration of €120,000.

 

As explained in the Company's Admission Document published on 11 December 2015, six additional managers of INVE, who were not shareholders in INVE at the time of its acquisition, were given the opportunity to invest in Benchmark ordinary shares at the placing price of 86 pence per share. Any such investment would also entitle them to receive share options under Part II of the Benchmark CSOP with a value of £40 for every £100 invested. The six managers have now agreed to invest approximately €120,000 in aggregate to acquire a total of 110,873 ordinary shares at the placing price, a premium of approximately 65% to the Company's current market price. As a result of this investment, these managers have also been awarded an aggregate of 44,349 Benchmark CSOP options.

 

All of the managers have agreed to restrictions on the disposal of the ordinary shares until October 2017 and orderly marketing provisions until April 2018. The restrictions are the same as the lock-in and orderly marketing agreements described in paragraph 14.16 of Part VII of the Company's Admission Document published on 11 December 2015.

 

An application has been made for the New Ordinary Shares to be admitted to trading on AIM ("Admission") and it expected that Admission will occur on 20 April 2016. Following Admission, the Company's issued share capital will comprise 474,068,952 Ordinary Shares. No shares are held in treasury. This figure of 474,068,952 may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

-Ends-

 

 

For further information, please contact:

 

Benchmark Holdings plc Tel: 020 7920 3150

Malcolm Pye, CEO

Roland Bonney, COO

Rachel Aninakwah, Communications

 

Cenkos Securities PLC Tel: 020 7397 8900

Ivonne Cantu / Stephen Keys (NOMAD)

Russell Kerr (Sales)

 

Tavistock Tel: 020 7920 3150

Matt Ridsdale/Niall Walsh

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOESFMSAAFMSEDL
Date   Source Headline
18th Oct 20217:00 amRNSTrading Statement
30th Sep 20217:00 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSEnvironmental recognition for CleanTreat®
21st Sep 20217:00 amRNSBlock Listing Six Monthly Return
31st Aug 20217:00 amRNSTotal Voting Rights
25th Aug 20217:00 amRNSEquity Development Investor Webinar
24th Aug 20217:00 amRNSQ3 Results
30th Jul 20217:00 amRNSTotal Voting Rights
15th Jul 20213:00 pmRNSAdoption of MRL for Ectosan Vet in Norway
2nd Jul 20213:20 pmRNSBMK08+CleanTreat and Trading Update
30th Jun 20217:00 amRNSTotal Voting Rights
21st Jun 20214:41 pmRNSSecond Price Monitoring Extn
21st Jun 20214:36 pmRNSPrice Monitoring Extension
2nd Jun 20214:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20214:35 pmRNSPrice Monitoring Extension
28th May 20217:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSDirector Dealings
18th May 20217:00 amRNSSecond Quarter and Interim results
30th Apr 20217:00 amRNSTotal Voting Rights
19th Apr 20217:00 amRNSNotice of Q2 and Interim Results
16th Apr 202111:00 amRNSBMK08+CleanTreat Update
31st Mar 20213:41 pmRNSDirector Dealings
31st Mar 20217:00 amRNSTotal Voting Rights
30th Mar 20217:00 amRNSListing of existing senior secured NOK bond
26th Mar 20218:24 amRNSBMK08+CleanTreat Update
19th Mar 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
26th Feb 202110:52 amRNSTotal Voting Rights
22nd Feb 20217:00 amRNSQ1 Results
9th Feb 202112:43 pmRNSResult of AGM
9th Feb 20217:00 amRNSNotice of Q1 Results
29th Jan 20217:00 amRNSTotal Voting Rights
13th Jan 20217:00 amRNSIssue of Equity
8th Jan 20211:13 pmRNSReplacement: DIRECTOR SHARE OPTIONS
8th Jan 20219:57 amRNSDIRECTOR SHARE OPTIONS
6th Jan 20213:45 pmRNSDirector Dealings
31st Dec 20207:00 amRNSTotal Voting Rights
11th Dec 20205:32 pmRNSPosting of Annual Report and Notice of AGM
2nd Dec 20202:09 pmRNSDirector Dealings
1st Dec 20204:02 pmRNSAnnual Financial Report
1st Dec 202011:30 amRNSDirector Dealings
1st Dec 202010:30 amRNSDirector Dealings
1st Dec 202010:21 amRNSPCA Dealing
30th Nov 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSQ4 Results
27th Nov 20207:00 amRNSFull Year Results
18th Nov 20207:00 amRNSDirectorate Change
4th Nov 20207:00 amRNSInvestor Presentation for Retail Investors
30th Oct 20207:00 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSNotice of Results
13th Oct 20202:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.